Profile
PDSB VRTX REGN ALNY SGEN ARGX
Company Name PDS Biotechnology Corporation Vertex Pharmaceuticals Incorporated Regeneron Pharmaceuticals, Inc. Alnylam Pharmaceuticals, Inc. Seagen Inc. argenx SE
Sector Healthcare Healthcare Healthcare Healthcare Healthcare Healthcare
Industry Biotechnology Biotechnology Biotechnology Biotechnology Biotechnology Biotechnology
Market Cap $56.68M $117.98B $60.26B $43.28B $43.15B $34.40B
Employees 0.02K 6.10K 15.16K 2.23K 3.26K 1.60K
CEO Frank K. Bedu-Addo Reshma Kewalramani FASN, Leonard S. Schleifer Yvonne L. Greenstreet David R. Epstein Timothy Van Hauwermeiren EMBA,
Ratings
PDSB VRTX REGN ALNY SGEN ARGX
Quant Rating Score 2 2 4 1 3 2
Quant Rating Sell Sell Buy Strong Sell Neutral Sell
Trading
PDSB VRTX REGN ALNY SGEN ARGX
Last Close $1.23 $472.35 $570.59 $315.75 $228.74 $561.28
High 52 $4.23 $516.74 $1201.76 $331.91 $228.74 $671.75
Low 52 $0.94 $396.64 $482.92 $224.58 $228.74 $461.01
Price vs. 52 Week High -70.92 % -8.59 % -52.52 % -4.87 % 0 % -16.45 %
Price vs. 52 Week Low 30.85 % 19.09 % 18.15 % 40.6 % 0 % 21.75 %
Total Return
PDSB VRTX REGN ALNY SGEN ARGX
1 Month Return -29.71 % 3.71 % 7.81 % 2.52 % 0 % -2.87 %
3 Month Return 10.81 % -5.62 % 2.27 % 36.79 % 0 % -7.24 %
6 Month Return -15.17 % 11.34 % -18.88 % 25.79 % 0 % -15.62 %
9 Month Return -61.92 % -2.47 % -43.87 % 9.88 % 0 % 3.04 %
YTD Return -24.54 % 17.3 % -19.9 % 34.18 % 0 % -8.73 %
1 Year Return -70.89 % -3.77 % -47.27 % 23.25 % 0 % 21.5 %
3 Year Return 0 % 0 % 0 % 0 % 0 % 0 %
5 Year Return 0 % 0 % 0 % 0 % 0 % 0 %
Dividends
PDSB VRTX REGN ALNY SGEN ARGX
Dividend Yield Percentage (TTM) - - 0.31 % - - -
Dividend Paid and Capex Coverage Ration (TTM) -1176.65 % -3.53 % 3.85 % -1.49 % -5.87 % -44.32 %
Dividend Per Share (TTM) - - 1.76 % - - -
Payout Ratio (TTM) - - 2.08 % - - -
Growth
PDSB VRTX REGN ALNY SGEN ARGX
Asset Growth -23.63 % -0.87 % 36.55 %
Gross Profit Growth -4.3 % 10.25 % 77.08 %
Revenue Growth - 11.66 % 78.6 %
Revenue 3 Year - 45.6 % 275.84 %
Revenue 5 Year - 163.93 % 1701.04 %
Revenue 10 Year - 1632.15 % 5950.81 %
EBIT Growth 15.78 % -93.69 % 128.87 %
Net Income Growth 12.42 % -114.8 % 382.34 %
Net Income 3 Yeari Growth Per Share -56.1 % -122.89 % 274.39 %
Net Income 5 Yeari Growth Per Share 28.24 % -145.38 % 396.61 %
Net Income 10 Yeari Growth Per Share 93.61 % 33.84 % 938.02 %
Operating Income Growth 15.62 % -106.08 % 94.91 %
Operating Cash Flow Growth (CFG) -4.14 % -113.93 % 80.31 %
Operating 3 Year CFG -97 % -118.65 % 88.36 %
Operating 5 Year CFG 74.12 % -131.3 % -135.21 %
Operating 10 Year CFG 92.53 % 12.43 % -64 %
EPS Growth -77558.27 % -114.8 % 369.77 %
EPS Diluted Growth -77558.27 % -114.97 % 347.67 %
Book Value Per Share -38.25 % -6.59 % 28.16 %
Share Holder 3 Year Equity Growth Per Share -78.89 % 62.6 % 85.14 %
Share Holder 5 Year Equity Growth Per Share -78.3 % 168.85 % 200.53 %
Share Holder 10 Year Equity Growth Per Share 101.41 % 1265.7 % 1039.11 %
Dividend Per Share Growth - - -
Dividend 3 Year Growth Per Share - - -
Dividend 5 Year Growth Per Share - - -
Dividend 10 Year Growth Per Share - - -
Debt Growth -8.49 % 116.42 % 95.27 %
Free Cash Flow Growth -4.23 % -124.1 % 67.46 %
Updated On 31 Dec 2024 31 Dec 2024 31 Dec 2024
Profitability
PDSB VRTX REGN ALNY SGEN ARGX
Gross Profit Margin TTM - 86.03 % 84.94 % 86.01 % 79.1 % 46.33 %
Return on Assets TTM -75.48 % -4.32 % 11.98 % -6.4 % -16.61 % 13.45 %
Return on Equity TTM -150.59 % -6.25 % 14.77 % -509.33 % -20.8 % 16.83 %
Return on Capital Employed TTM -122.83 % -3.89 % 11.35 % -3.68 % -21.46 % -0.5 %
Net Income Per EBT TTM 94.57 % 329.41 % 90.27 % 75.89 % 101.33 % 25990.14 %
EBT Per Ebit TTM 106.24 % 40.44 % 129.3 % 308.03 % 98.26 % -11.64 %
EBIT Per Revenue TTM - -6.69 % 27.37 % -4.91 % -31.24 % -1.24 %
Cash Flow To Debt Ratio TTM -179.97 % -59.44 % 146.15 % -3.47 % -1043.73 % -201.37 %
Receivables Turnover TTM - 6.15 2.53 5.62 3.91 2.46
Payables Turnover TTM 0.02 3.49 3.01 3.37 1.97 2.39
Inventory Turnover TTM - 1.14 0.66 5.01 0.96 2.93
Fixed Asset Turnover TTM - 421.34 % 300.07 % 337.41 % 665.41 % 4929.48 %
Asset Turnover TTM - 48.51 % 37.52 % 55.72 % 53.41 % 35.83 %
Operating Cash Flow Per Share TTM -0.84 -3.82 37.05 -0.35 -2.46 -1.07
Free Cash Flow Per Share TTM -0.84 -4.9 28.3 -0.58 -2.88 -1.09
Cash Per Share TTM 98.66 % 2413.86 % 7825.12 % 2024.29 % 939.52 % 4688.94 %
Operating Cash Flow Sales Ratio TTM - -8.83 % 28.06 % -1.92 % -23.12 % -3.54 %
Free Cash Flow Operating Cash Flow Ratio TTM 100.08 % 128.33 % 76.4 % 167.11 % 117.04 % 102.26 %
Cash Flow Coverage Ratios TTM -179.97 % -59.44 % 146.15 % -3.47 % -1043.73 % -201.37 %
Price To Free Cash Flows Ratio TTM -1.66 -93.78 19.95 -574.08 -81.26 -443.33
Price To Operating Cash Flows Ratio TTM -1.47 -120.39 15.32 -954.11 -93.1 -526.76
Price Cash Flow Ratio TTM -1.47 -120.39 15.32 -954.11 -93.1 -526.76
Income Statement (TTM)
PDSB VRTX REGN ALNY SGEN ARGX
Revenue $0B $11.02B $14.2B $2.25B $1.96B $2.19B
Gross Profit $-0B $9.49B $12.23B $1.92B $1.55B $1.96B
Gross Profit Ratio 0% 86.11% 86.13% 85.62% 79.1% 89.62%
EBITDA $-0.03B $0.49B $5.32B $-0.18B $-0.62B $0.11B
Net Income $-0.04B $-0.54B $4.41B $-0.28B $-0.61B $0.83B
EPS Diluted -1079.45 -2.08 38.34 -2.16 -3.3 12.78
Balance Sheet (MRQ)
PDSB VRTX REGN ALNY SGEN ARGX
Long Term Debt $0.01B $1.66B $1.98B $0B $0.04B $0.03B
Total Liabilities $0.03B $6.12B $8.41B $4.17B $0.87B $0.7B
Total Equity $0.02B $16.41B $29.35B $0.07B $2.8B $5.5B
Total Investments $0B $6.65B $15.42B $1.73B $1.42B $1.93B
Total Debt $0.02B $1.75B $2.7B $1.3B $0.04B $0.04B
Total Assets $0.05B $22.53B $37.76B $4.3B $3.67B $6.2B
Cash Flow Statement (TTM)
PDSB VRTX REGN ALNY SGEN ARGX
Net Income $-0.04B $-0.54B $4.41B $-0.28B $-0.61B $-0.02B
Inventory $0B $-0.52B $-0.62B $0.01B $-0.23B $-0.09B
Dividends Paid $0B $0B $0B $0B $0B $0B
Operating Cash Flow $-0.04B $-0.49B $4.42B $-0.01B $-0.45B $-0.08B
Capital Expenditure $-0B $-0.3B $-0.76B $-0.03B $-0.08B $-0.07B
Related Stocks
Ticker Name Price
AADI Aadi Bioscience, Inc. 2.05
AAPG 36.79
AARD Aardvark Therapeutics, Inc. Common Stock 11.595
ABCL AbCellera Biologics Inc. 3.93
ABCM Abcam plc 23.99
ABEO Abeona Therapeutics Inc. 5.955
ABIO ARCA biopharma, Inc. 28.8
ABOS Acumen Pharmaceuticals, Inc. 1.3147
ABPWW 0.0387
ABSI Absci Corporation 2.56
ABUS Arbutus Biopharma Corporation 3.12
ABVC ABVC BioPharma, Inc. 3.55
ABVX Abivax SA American Depositary Shares 8.86
ACAD ACADIA Pharmaceuticals Inc. 22.02
ACER Acer Therapeutics Inc. 0.6601
ACET Adicet Bio, Inc. 0.7626
ACGN Aceragen, Inc. 0.3849
ACHL Achilles Therapeutics plc 1.48
ACHV Achieve Life Sciences, Inc. 2.635
ACIU AC Immune SA 2.04
ETFs With Exposure to PDSB
Ticker ETF Name Weight Percentage Price
IWM iShares Russell 2000 ETF 0.00304 218.93
VTI Vanguard Total Stock Market Index Fund 0 306.12
ITOT iShares Core S&P Total U.S. Stock Market ETF 0.00027 135.98
IWO iShares Russell 2000 Growth ETF 0.00569 287.03
VXF Vanguard Extended Market Index Fund 0 194.505
HDG ProShares Hedge Replication ETF 0.000521282 49.8863
UWM ProShares Ultra Russell2000 0.00103758 38.61
VTHR Vanguard Russell 3000 Index Fund 0 274.6
IWC iShares Micro-Cap ETF 0.01514 130.64
URTY ProShares UltraPro Russell2000 0.000492602 40.75
BTEC Principal Healthcare Innovators ETF 0.0440667 39.49
SBIO ALPS Medical Breakthroughs ETF 0.0012 32.31
VFMO Vanguard U.S. Momentum Factor ETF 0.02 172.32
VTWG Vanguard Russell 2000 Growth Index Fund 0.01 209.67
VTWO Vanguard Russell 2000 Index Fund 0 88.5
VITNX Vanguard Institutional Total Stock Market Index Fund Institutional Shares 0 104.67
VITPX Vanguard Institutional Total Stock Market Index Fund Institutional Plus Shares 0 104.65
VBAIX Vanguard Balanced Index Fund Institutional Shares 0 50.06
VBIAX Vanguard Balanced Index Fund Admiral Shares 0 50.05
VBINX Vanguard Balanced Index Fund Investor Shares 0 50.05
RYLD Global X Russell 2000 Covered Call ETF 0.01 15.025
AVUS Avantis U.S. Equity ETF 0 101.545
DFAU Dimensional US Core Equity Market ETF 0.00000015 42.66
DFAS Dimensional U.S. Small Cap ETF 0.00005099 64.295
DFAC Dimensional U.S. Core Equity 2 ETF 0.00002717 36.115
VTSAX Vanguard Total Stock Market Index Fund 0 149.82
VIEIX Vanguard Extended Market Index Fund Institutional Shares 0 149.84
VITSX Vanguard Total Stock Market Index Fund 0 149.84
QQQS Invesco NASDAQ Future Gen 200 ETF 0.266 27.583
DFSU Dimensional US Sustainability Core 1 ETF 0.00000265 39.45
SWTSX Schwab Total Stock Market Index Fd Select Shs a Series of Schwab Capit 0.000169445 106
VEXAX Vanguard Extended Market Index Fd Admiral Shs 0 149.85
SWSSX Schwab Small-Cap Index Fund-Select Shares 0.00321515 36.31
TYNE Direxion Nanotechnology ETF 1.28592 17.2638
JKK iShares Morningstar Small-Cap Growth ETF 0.01 307.42
JKJ iShares Morningstar Small-Cap ETF 0.01 231.193
AVSC Avantis U.S. Small Cap Equity ETF 0 52.69
VEMPX Vanguard Extended Market Index InstlPlus 0 369.78
VSMPX Vanguard Total Stock Mkt Idx Instl Pls 0 281.08
RSSL Global X Funds 0 85.965
Unlock